Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPIBRAINRAD : Study of Neurological Complication After Radiotherapy for Glioblastoma High Grade

NCT02544178 is registered in ClinicalTrials.gov with Sophie JACOB as lead sponsor.

NCT NCT02544178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02544178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPIBRAINRAD : Study of Neurological Complication After Radiotherapy for Glioblastoma High Grade
Lead sponsor
Sophie JACOB
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2015
Completion date
April 30, 2020
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukoencephalopathy